News & Info
INTERVIEWS & ARTICLES
PRESS RELEASES
- Burzynski Research Institute Signs Research Agreement with the University of Alabama at Birmingham (UAB), Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility..
September 28, 2009 (PDF)
- Burzynski Research Institute Announces Presents Positive Results from Phase II Trials of ANP for Inoperable Brainstem Glioma at the Congress..
May 11, 2009 (PDF)
- Burzynski Research Institute Announces Positive Results of Phase II ANP Clinical Trial..
May 6, 2009 (PDF)
- Physicians from the Burzynski Clinic Present Initial Results of Combination Gene-Targeting Therapies on Advanced Pancreatic and Liver Cancers..
February 5, 2009 (PDF)
- Burzynski Research Institute Partners with Premier Research to Manage Phase III Clinical Study of Children with Newly-Diagnosed Diffuse Intrinsic Brainstem Glioma..
January 26, 2009 (PDF)
- Burzynski Research Institute Gets SPA Clearance from the FDA to Initiate Pivotal Phase III Trial of Combination Antineoplaston Therapy and Radiation Therapy.
January 13, 2009 (PDF)
- U.S. FDA Grants Orphan Drug Designation for Burzynski Research Institutes Antineoplaston Treatment for Gliomas
December 2, 2008 (PDF)
- Burzynski Research Institute, Inc. Presents Promising Phase II Data on Malignant Glioma
November 21, 2008 (PDF)
- Thought Leaders from Burzynski Research Institute Inc Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
November 20, 2008 (PDF)
|
|
|
